Zepbound is off to a good start, but here's what Eli Lilly investors are watching

Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…

FAA chief promises 'boots on the ground' for quality control

Michael Whitaker, candidate to be the next administrator of the Federal Aviation Administration (FAA), testifies during a Senate Commerce, Science…